344 related articles for article (PubMed ID: 18042267)
1. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
Kim HN; Lee IK; Kim YK; Tran HT; Yang DH; Lee JJ; Shin MH; Park KS; Shin MG; Choi JS; Kim HJ
Br J Haematol; 2008 Feb; 140(3):287-94. PubMed ID: 18042267
[TBL] [Abstract][Full Text] [Related]
2. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.
Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311
[TBL] [Abstract][Full Text] [Related]
3. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.
Timuragaoglu A; Dizlek S; Uysalgil N; Tosun O; Yamac K
Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
[TBL] [Abstract][Full Text] [Related]
6. Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring.
Coppedè F; Migheli F; Bargagna S; Siciliano G; Antonucci I; Stuppia L; Palka G; Migliore L
Neurosci Lett; 2009 Jan; 449(1):15-9. PubMed ID: 18983896
[TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies.
Kim HN; Kim YK; Lee IK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Park MR; Jo DY; Won JH; Kwak JY; Kim HJ
Leuk Res; 2009 Jan; 33(1):82-7. PubMed ID: 18774170
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk.
Lima CS; Ortega MM; Ozelo MC; Araujo RC; De Souza CA; Lorand-Metze I; Annichino-Bizzacchi JM; Costa FF
Leuk Res; 2008 Mar; 32(3):401-5. PubMed ID: 17655928
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase and methionine synthase reductase gene polymorphisms and protection from microvascular complications in adolescents with type 1 diabetes.
Wiltshire EJ; Mohsin F; Chan A; Donaghue KC
Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):348-53. PubMed ID: 18774994
[TBL] [Abstract][Full Text] [Related]
11. Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk.
Suzuki T; Matsuo K; Sawaki A; Mizuno N; Hiraki A; Kawase T; Watanabe M; Nakamura T; Yamao K; Tajima K; Tanaka H
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2742-7. PubMed ID: 18843018
[TBL] [Abstract][Full Text] [Related]
12. Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer.
Marchal C; Redondo M; Reyes-Engel A; Perea-Milla E; Gaitan MJ; Machuca J; Diaz F; Caballero J; Carnero J
Eur J Surg Oncol; 2008 Jul; 34(7):805-10. PubMed ID: 17967524
[TBL] [Abstract][Full Text] [Related]
13. Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes.
Lightfoot TJ; Skibola CF; Willett EV; Skibola DR; Allan JM; Coppede F; Adamson PJ; Morgan GJ; Roman E; Smith MT
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2999-3003. PubMed ID: 16365025
[TBL] [Abstract][Full Text] [Related]
14. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.
Suzuki T; Matsuo K; Hiraki A; Saito T; Sato S; Yatabe Y; Mitsudomi T; Hida T; Ueda R; Tajima K
Carcinogenesis; 2007 Aug; 28(8):1718-25. PubMed ID: 17468511
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase gene polymorphisms (677C > T and 1298A > C) in Egyptian patients with non-Hodgkin lymphoma.
Nasr AS; Sami RM; Ibrahim NY
J Cancer Res Ther; 2012; 8(3):355-60. PubMed ID: 23174714
[TBL] [Abstract][Full Text] [Related]
16. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic.
Pardini B; Kumar R; Naccarati A; Prasad RB; Forsti A; Polakova V; Vodickova L; Novotny J; Hemminki K; Vodicka P
Mutat Res; 2011 Mar; 721(1):74-80. PubMed ID: 21211571
[TBL] [Abstract][Full Text] [Related]
17. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China.
Stolzenberg-Solomon RZ; Qiao YL; Abnet CC; Ratnasinghe DL; Dawsey SM; Dong ZW; Taylor PR; Mark SD
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1222-6. PubMed ID: 14652285
[TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma.
Matsuo K; Hamajima N; Suzuki R; Ogura M; Kagami Y; Taji H; Yasue T; Mueller NE; Nakamura S; Seto M; Morishima Y; Tajima K
Am J Hematol; 2004 Dec; 77(4):351-7. PubMed ID: 15551285
[TBL] [Abstract][Full Text] [Related]
19. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study.
Le Marchand L; Haiman CA; Wilkens LR; Kolonel LN; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2071-7. PubMed ID: 15598763
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population.
Rouissi K; Ouerhani S; Oliveira E; Marrakchi R; Cherni L; Ben Othman F; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; Prata MJ; Benammar Elgaaied A
Cancer Genet Cytogenet; 2009 Nov; 195(1):43-53. PubMed ID: 19837268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
